Publications in collaboration with researchers from Instituto de Investigaciones Biomédicas de Barcelona (10)

2024

  1. Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

    Biomedicine and Pharmacotherapy, Vol. 176

2023

  1. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

2022

  1. Electrochemical immunosensing of Growth arrest-specific 6 in human plasma and tumor cell secretomes

    Electrochemical Science Advances, Vol. 2, Núm. 4

2021

  1. Electrochemical immunosensing of st2: A checkpoint target in cancer diseases

    Biosensors, Vol. 11, Núm. 6

2020

  1. Galectins in the Tumor Microenvironment: Focus on Galectin-1

    Advances in Experimental Medicine and Biology (Springer), pp. 17-38

  2. Impact of galectins in resistance to anticancer therapies

    Clinical Cancer Research, Vol. 26, Núm. 23, pp. 6086-6101

  3. The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer

    Cells, Vol. 9, Núm. 3

2019

  1. Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities

    Nature Reviews Urology, Vol. 16, Núm. 7, pp. 433-445

2018

  1. Immune evasion in pancreatic cancer: From mechanisms to therapy

    Cancers, Vol. 10, Núm. 1

  2. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Núm. 16, pp. E3769-E3778